B anthracis."1 In other words, as I said in my editorial, currently no field evidence exists of AVA's effectiveness against inhalation anthrax in humans. In my view no amount of political window dressing can change this fact. Winkenwerder and Grabenstein believe that laboratory evidence from animals and humans using surrogate outcomes such as antibody responses coupled with "reasonable assumptions